NCT06288165Recruiting
Lower Silesia Sinus Reducer Registry
Coronary Sinus Reducer Implantation for Refractory Angina - Long-Term Evaluation of Device Safety and Efficacy- Lower Silesia Sinus Reducer Registry (LSSRR)
Source: ClinicalTrials.gov · Last updated 1 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Lower Silesia Sinus Reducer Registry is a , single-center, single-arm registry including patients with chronic disabling refractory angina pectoris (Canadian Cardiovascular Society \[CCS\] classes 2-4) despite maximally tolerated anti-angina medical therapy who underwent Coronary Sinus Reducer implantation .
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 18 Feb 2024
- Start date
- 11 May 2022
- Primary completion date
- 11 May 2027
- Lead sponsor
- Miedziowe Centrum Zdrowia SA
- Diseases
- Coronary artery disease
- NCT number
- NCT06288165
What you commit to
- Study type: Observational
- Planned participants: 200
- From 11 May 2022 to the primary completion date, 11 May 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- recent acute coronary syndrome (\<3 months),
- advanced heart failure (New York Heart Association \[NYHA\] Classification - classes 3-4),
- potential implantable cardiac resynchronization therapy defibrillator (CRT-D) implantation candidate.
Other
- recent coronary revascularization (\<3 months)
- a mean right atrial pressure higher than 15 mm Hg
- coronary sinus proximal diameter \<10mm and \>14mm
- life expectancy under 12 months,
Who the study is looking for
- present of chronic disabling refractory angina pectoris (Canadian Cardiovascular Society \[CCS\] classes 2-4) despite maximally tolerated anti-angina medical therapy
- Heart team evaluation with consideration of ineligibility for percutaneous or surgical revascularization procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology, The Copper Health Centre (MCZ) Coordinator of this site? Confirm its status | Lubin | Poland | Recruiting |
| Cardiac Department of Copper Health Center Coordinator of this site? Confirm its status | Lubin | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.